Ver Publicación - Prisma - Unidad de Bibliometría

Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis

Fang, ZJ; Fattori, GC; Mckerrell, T; Boucher, RH; Jackson, A; Fletcher, RS; Forte, D; Martin, JE; Fox, S; Roberts, J; Glover, R; Harris, E; Bridges, HR; Grassi, L; Rodriguez-Meira, A; Mead, AJ; Knapper, S; Ewing, J; Butt, NM; Jain, M; Francis, S; Clark, FJ; Coppell, J; Mcmullin, MF; Wadelin, F; Narayanan, S; Milojkovic, D; Drummond, MW; Sekhar, M; Eldaly, H; Hirst, J; Paramor, M; Baxter, EJ; Godfrey, AL; Harrison, CN ; Méndez-Ferrer, S 

Tipo: Artículo
Año de Publicación: 2023
Volumen: 14
Número: 1
Número de artículo: 7725
Acceso abierto: Vía dorada
No hay citas para esta publicación
Dimensions
PlumX
Altmetric

Año: 2023

Journal Impact Factor (JIF): 14.70

CategoríaEdiciónPosiciónCuartilTercilDecil
MULTIDISCIPLINARY SCIENCESSCIE8/134Q1T1D1

Año: 2023

Journal Citation Indicator (JCI): 3,280

CategoríaPosiciónCuartilTercilDecilPercentil
MULTIDISCIPLINARY SCIENCES8/135Q1T1D194,44

Año:

2023

CiteScore:

24,900

CategoríaPosiciónCuartilTercilDecil
Biochemistry, Genetics and Molecular Biology (all)7/221Q1T1D1
Chemistry (all)16/408Q1T1D1
Physics and Astronomy (all)7/243Q1T1D1

SJR año:

2023

Factor de Impacto:

4,887

CategoríaPosiciónCuartilTercilDecil
Biochemistry, Genetics and Molecular Biology (miscellaneous)11/304Q1T1D1
Chemistry (miscellaneous)14/495Q1T1D1
Physics and Astronomy (miscellaneous)9/304Q1T1D1
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
-C61367/A26670
AIL Bologna ODV-
Associazione "Amici di Beat Leukemia Dr. Alessandro Cevenini ONLUS"-
Associazione Italiana Ricerca sul Cancro (AIRC-Fellowship)20930
Blood Cancer UK under the Trials Acceleration Programme (TAP)-
Cambridge Experimental Cancer Medicine Centre, UK-
Cambridge NIHR Biomedical Research Centre-
CSC-Cambridge Trust Scholarship-
European UnionERC-2014-CoG-648765
Medical Research CouncilMC_UU_00015/2
MRCMR/V005421/1; MC_PC_17230
MRC-AMED grant-
National Health Service Blood and Transplant (United Kingdom)-
NIHR Starter Grant for Clinical LecturersSGL018/1032
Programme Foundation Award from Cancer Research UK203151/Z/16/Z
Societ Italiana di Ematologia (SIE)-
UKRI Medical Research CouncilMR/V005421/1
Wellcome TrustMC_PC_17230
Wellcome Trust - MRC Stem Cell Institute-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Fang, ZJUniversity of Cambridge Department of Haematology; NHS Blood & Transplant; Wellcome MRC Cambridge Stem Cell Inst (England)
2Fattori, GCUniversity of Cambridge Department of Haematology; NHS Blood & Transplant; Wellcome MRC Cambridge Stem Cell Inst (England)
3Mckerrell, TUniversity of Cambridge; NHS Blood & Transplant; Wellcome MRC Cambridge Stem Cell Inst (England)
4Boucher, RHUniversity of Birmingham Cancer Research UK Clinical Trials Unit (England)
5Jackson, AUniversity of Birmingham Cancer Research UK Clinical Trials Unit (England)
6Fletcher, RSUniversity of Birmingham Cancer Research UK Clinical Trials Unit (England)
7Forte, DUniversity of Cambridge Department of Haematology; NHS Blood & Transplant; Wellcome MRC Cambridge Stem Cell Inst (England)
8Martin, JEUniversity of Cambridge (England)
9Fox, SUniversity of Birmingham Cancer Research UK Clinical Trials Unit (England)
10Roberts, JUniversity of Cambridge Department of Haematology (England)
11Glover, RUniversity of Cambridge Department of Haematology (England)
12Harris, EUniversity of Cambridge Department of Haematology (England)
13Bridges, HRMRC Mitochondrial Biology Unit (England)
14Grassi, LUniversity of Cambridge Department of Haematology (England)
15Rodriguez-Meira, AWeatherall Institute of Molecular Medicine; Nuffield Department of Clinical Laboratory Sciences (England)
16Mead, AJWeatherall Institute of Molecular Medicine; Nuffield Department of Clinical Laboratory Sciences (England)
17Knapper, SCardiff University School of Medicine (Wales)
18Ewing, JUniversity of Birmingham (England)
19Butt, NMClatterbridge Canc Ctr NHS Fdn Trust (England)
20Jain, MSaint James's University Hospital (England)
21Francis, SUniversity of Sheffield (England)
22Clark, FJUniversity of Birmingham (England)
23Coppell, JUniversity of Exeter (England)
24Mcmullin, MFQueens University Belfast (North Ireland)
25Wadelin, FUniversity of Nottingham (England)
26Narayanan, SUniv Hosp Southampton NHSFT (England)
27Milojkovic, DImperial College London (England)
28Drummond, MWBeatson Oncology Centre (Scotland)
29Sekhar, MUniversity College London (England)
30Eldaly, HUniversity of Cambridge (England)
31Hirst, JMRC Mitochondrial Biology Unit (England)
32Paramor, MWellcome MRC Cambridge Stem Cell Inst (England)
33Baxter, EJUniversity of Cambridge Department of Haematology (England)
34Godfrey, ALUniversity of Cambridge (England)
35Harrison, CN Guy's & St Thomas' NHS Foundation Trust (England)
36Méndez-Ferrer, S University of Cambridge Department of Haematology; NHS Blood & Transplant; Wellcome MRC Cambridge Stem Cell Inst (England)